PubRank

Hiroya Tamaki

Author PubWeight™ 24.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood 2002 2.25
2 Neddylation plays an important role in the regulation of murine and human dendritic cell function. Blood 2013 1.69
3 Donor-derived T-cell leukemia after bone marrow transplantation. N Engl J Med 2006 1.53
4 High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 2002 1.49
5 Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation study. Leuk Res 2012 1.42
6 Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer 2002 1.32
7 PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6. J Immunol 2013 1.04
8 Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells. Br J Haematol 2002 1.02
9 Allogeneic T cell responses are regulated by a specific miRNA-mRNA network. J Clin Invest 2013 0.98
10 Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies. Blood 2002 0.98
11 CD48 as a novel molecular target for antibody therapy in multiple myeloma. Br J Haematol 2011 0.89
12 Donor- but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease. J Leukoc Biol 2012 0.86
13 False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma. Eur J Haematol 2007 0.85
14 Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. Exp Hematol 2007 0.81
15 Influence of donor microbiota on the severity of experimental graft-versus-host-disease. Biol Blood Marrow Transplant 2012 0.80
16 Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation. Ann Hematol 2012 0.79
17 Intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: a phase I study. Biol Blood Marrow Transplant 2011 0.78
18 FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway. Cell Signal 2013 0.78
19 Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes. Leuk Lymphoma 2012 0.77
20 Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation. Int J Hematol 2011 0.77
21 Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning. Int J Hematol 2014 0.77
22 Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells. Int J Hematol 2010 0.77
23 Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. Biol Blood Marrow Transplant 2008 0.76
24 [Clinical course of the disease and the level of WT1 mRNA in 191 patients with acute myeloid leukemia (AML): joint research by 23 institutions in Japan]. Rinsho Ketsueki 2005 0.76
25 Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation. Transplantation 2002 0.76
26 Successful remission induction by low-dose all-trans retinoic acid alone in a patient with acute promyelocytic leukemia and renal impairment. Leuk Res 2007 0.75
27 Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation. Exp Hematol 2011 0.75
28 WT1 gene transcript assay for relapse in acute leukemia after transplantation. Leuk Lymphoma 2004 0.75
29 Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation. Ann Hematol 2015 0.75
30 Different kinetics of WT1 and PML-RARalpha gene expression levels during remission induction therapy with all-trans retinoic acid alone in acute promyelocytic leukemia. Int J Hematol 2006 0.75
31 [Molecular quantitation of minimal residual disease in leukemia]. Nihon Naika Gakkai Zasshi 2003 0.75
32 Kinetics of granulocyte colony-stimulating factor in the human milk of a nursing donor receiving treatment for mobilization of the peripheral blood stem cells. Acta Haematol 2007 0.75
33 Detection of donor-derived CMV-specific T cells in cerebrospinal fluid in a case of CMV meningoencephalitis after cord blood stem cell transplantation. Int J Hematol 2012 0.75
34 Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation. Leuk Res 2011 0.75
35 Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients. Int J Hematol 2012 0.75
36 Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene. Int J Hematol 2011 0.75
37 Curative resection of double primary lung cancer after 15-month bortezomib administration. Onkologie 2012 0.75
38 Dasatinib is effective against optic nerve infiltration of Philadelphia chromosome-positive acute lymphoblastic leukemia. Leuk Lymphoma 2010 0.75